Combinaison d’organoïdes humains et de la technologie Organ-on-a-Chip pour modéliser des fonctionnalités spécifiques à la région intestinale

Overview

This protocol demonstrates the integration of biopsy-derived intestinal organoids with organ-on-a-chip technology to create a microphysiological platform that mimics the functionality of the human intestine. This innovative approach allows for the study of pharmacokinetics, drug-drug interactions, and intestinal barrier dysfunction.

Key Study Components

Area of Science

• Neuroscience
• Biology
• Pharmacology

Background

• Biopsy-derived intestinal organoids provide a model for studying intestinal physiology.
• Organ-on-a-chip technology enhances the experimental control of biological systems.
• This method allows for the reproduction of the complex intestinal epithelium.
• Understanding gut functions is crucial for drug development and disease prevention.

Purpose of Study

• To create a physiologically relevant intestine chip.
• To predict pharmacokinetics and drug interactions.
• To study intestinal epithelial barrier dysfunction.

Methods Used

• Integration of organoids with organ-on-a-chip technology.
• Control of mechanical cues and biochemical gradients.
• Seeding of organoids as a critical step in the protocol.
• Emulation of human intestinal physiology.

Main Results

• The platform successfully mimics the complexity of the human intestine.
• Enhanced understanding of cellular and molecular gut functions.
• Improved predictions of pharmacokinetics and pharmacodynamics.
• Potential to identify drug candidates that prevent inflammatory damage.

Conclusions

• The microphysiological platform is a valuable tool for intestinal research.
• It provides insights into normal and pathological gut functions.
• This approach can aid in the development of new therapeutic strategies.

Frequently Asked Questions